ASX-listed medical device company Cochlear Limited (ASX:COH) Limited provided an update on the impact of COVID-19 pandemic to its current trading conditions.
The Company disclosed that sales revenue across the business dropped by ~60% in April with cochlear as well as acoustic implants severely affected.
Cochlear implant unit sales dwindled by ~80% across developed markets, with most elective surgeries delayed across Western Europe and the United States.
Disclaimer
There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.
Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.
As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.
